2,851
edits
Insulin/IGF-1 Signaling (IIS) Pathway: Difference between revisions
Insulin/IGF-1 Signaling (IIS) Pathway (view source)
Revision as of 01:29, 15 January 2024
, 15 Januaryno edit summary
No edit summary |
|||
| Line 16: | Line 16: | ||
The manipulation of the IIS pathway offers potential therapeutic avenues for age-related diseases, including diabetes, neurodegenerative diseases, and cancer. Pharmacological agents that can modulate this pathway may have significant implications in promoting healthy aging and longevity. | The manipulation of the IIS pathway offers potential therapeutic avenues for age-related diseases, including diabetes, neurodegenerative diseases, and cancer. Pharmacological agents that can modulate this pathway may have significant implications in promoting healthy aging and longevity. | ||
==References== | ==References== | ||
[[Category:Pathway]] | |||